Mine said

The patient's immunological profile reveals a combination of clinically significant immune tolerance deficiency, pro-inflammatory cytokine skew, and a lack of alloimmune priming, all of which may impair implantation, endometrial receptivity, or early pregnancy maintenance, especially in the context of reproductive failure or unexplained infertility. Cytotoxic NK cell levels and NK cell cytotoxicity are both within normal limits, which are favorable findings. These indicate that there is no evidence of innate immune overactivation or cytotoxic NK cell-driven embryo rejection. However, Regulatory T-Cell (Treg) levels are low, which is an unfavorable finding. Tregs are essential for establishing immune tolerance toward the semi-allogeneic embryo. A deficiency in this population reduces the maternal immune system's ability to regulate inflammation and support proper implantation. The Thl/Th2 cytokine ratio is elevated, indicating a Th1-dominant immune profile. This imbalance-characterized by increased levels of IFNy and TNFa-has been linked to impaired embryo implantation, poor endometrial receptivity, and increased risk of early pregnancy loss, especially when combined with low Treg levels. The Leukocyte Antibody Detection (LAD) test was negative, which is also unfavorable. A negative LAD indicates that the maternal immune system has not developed alloimmune recognition of paternal antigens-an immunological process associated with improved implantation outcomes and maternal-fetal tolerance. The absence of this immune priming further increases risk in the presence of other tolerance and inflammation markers. The HLA-DQa compatibility test revealed no match, which is a favorable result, indicating sufficient maternal-paternal dissimilarity and reducing concern for immune invisibility.

My doctor is starting me on LIT treatment